NewAmsterdam Pharma Company N.V.
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has NewAmsterdam Pharma Company N.V.'s balance sheet done over the years? Its assets were worth $347,097,000 last year, which is less than in the previous period. 17% of NewAmsterdam Pharma Company N.V.’s total assets is currently financed by debt. Its liabilities reached the amount of $58,704,000, which means an increase by 25% compared compared to last year.

Debt to Assets

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS): Debt to assets
2020 9231000 12.80M 138.75%
2021 59782000 9.99M 16.71%
2022 531583000 47.06M 8.85%
2023 347097000 58.70M 16.91%

NAMS Balance Sheet (2020 – 2023)

2023 2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
340.45M438.52M53.09M7.86M
Short term investments
0000
Net receivables
1.88M1.94M4.29M0
Inventory
021.5K-7350
Other current assets
4.46M7.64M1.49M411.65K
Total current assets
346.79M448.13M58.87M9.21M
Non-current assets:
Property, Plant and Equipment
101K144K190K12K
Goodwill
0233.10K00
Intangible assets
170K82.92M00
Long term investments
00718.35K112.78M
Other non-current assets
35K146K-353-112.78M
Total non-current assets
306K83.45M908K12K
Total assets
347.09M531.58M59.78M9.23M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
8.94M13.00M3.60M0
Short term debt
60K62K53K11.65M
Total current liabilities
49.89M35.46M9.88M12.80M
Non-current liabilities:
Long term debt
056K111K0
Deferred tax
0000
Other non-current liabilities
7.78M7.05M09.94M
Total non-current liabilities
8.80M11.60M111K9.94M
Total liabilities
58.70M47.06M9.99M12.80M
Data sourceData source